-
to investigate structure-activity relationships that will enable the future efficient design of potent mRNA LNP therapeutics. CureVac has been focusing on innovations in the lipid space for the design and in vitro
-
to investigate such effects. In this project, we will therefore explore membrane mimics of increasing complexity in combination with nanoparticles designed for the delivery of mRNA and proteins to combat disease
-
tomography, scattering and spectroscopy, to understand knee tissues during OA. Detailed description of the work duties: You will be responsible for designing, planning, and performing experiments, including
-
synchrotron science. All applicants are strongly encouraged to contact the supervisor Felix Roosen-Runge for further information on the research design of the postdoctoral project. Qualification requirements
-
teaching and learning. The purpose of the position is to develop the independence as a researcher and to create the opportunity of further development. You will have the main task in designing and performing
-
postdoctoral scientist is sought to work on a project designed to extend our understanding of the molecular basis of transthyretin amyloidosis Read more here. Human transthyretin (TTR) is a protein that
-
the European Commission, a background in the relevant methods, a complete application package submitted through the AMBER portal (including CV and detailed research plan), strict compliance with the MSCA
-
the European Commission, a background in the relevant methods, a complete application package submitted through the AMBER portal (including CV and detailed research plan), strict compliance with the MSCA
-
, at least one original publication in a peer-reviewed journal, a background in the relevant methods, a complete application package submitted through the AMBER portal (including CV and detailed research plan
-
relevant methods, a complete application package submitted through the AMBER portal (including CV and detailed research plan), and finally, strict compliance with the MSCA mobility rule that the researcher